alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 32.1**

 

**CertificationPursuant to**

**18 U.S.C. Section 1350**

**(As AdoptedPursuant to**

**Section 906of the Sarbanes-Oxley Act of 2002)**

 

In connection with this Quarterly Report on Form 10-Qof Weida Communications, Inc. (the “Company”) for the quarterly periodended March 31, 2005 as filed with the Securities and Exchange Commissionon the date hereof (the “Report”), Mitchell Sepaniak, as President and ChiefExecutive Officer of the Company, and Meilin Yu, as Acting Chief FinancialOfficer of the Company, each hereby certifies, pursuant to 18 U.S.C. §1350, asadopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to thebest of each such officer’s knowledge:

 

(1)                 The Report fully complies with therequirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and

 

(2)                 The information contained in the Report fairlypresents, in all material respects, the financial condition and results ofoperations of the Company.

 

 
|   |                                        | /s/ Mitchell Sepaniak |   |
|--------|---------------------------------------------|-----------------------|--------|
| Name:  | **Mitchell  Sepaniak**                      |                  |
| Title: | **President  and Chief Executive  Officer** |                  |
| Date:  | **June 13,  2005**                     |                  |
|        |                                             |                       |        |  |

 
|   |                                | /s/ Meilin Yu |   |
|--------|-------------------------------------|---------------|--------|
| Name:  | **Meilin Yu**                       | ** **    |
| Title: | **Acting  Chief Financial Officer** |          |
| Date:  | **June 13,  2005**             |          |
|        |                                     |               |        |  |

 

This certification accompanies the Report pursuant toSection 906 of the Sarbanes-Oxley Act of 2002 and shall not, except toextent required by the Sarbanes-Oxley Act of 2002, be deemed filed by theCompany for purposes of Section 18 of the Securities Exchange Act of 1934,as amended.

 

A signed original of this written statement requiredby Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to theCompany and will be retained by the Company and furnished to the Securities andExchange Commission or its staff upon request.

 

----
Exhibit 31.1



CERTIFICATION OF PRINCIPAL EXECUTIVE
OFFICER

PURSUANT TO

SECTION 13(a) OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT
OF 2002



I, Pankaj Mohan, certify that:



| | 1. | I have reviewed this Amendment No. 1 to the Annual Report
on Form 10-K of Oncobiologics, Inc. (the “registrant”); and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | Based on my knowledge, this report does not contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this report.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



Date: January 29, 2018



|/s/ Pankaj Mohan                      | 
|------------------------------------- | 
|Pankaj Mohan, Ph.D.                   | 
|President and Chief Executive Officer |
Editorial Note on Part 878
Editorial Note: Nomenclature changes to part 878 appear at 73 FR 35341, June 23, 2008.

§ 878.4015 Wound dressing with poly (diallyl dimethyl ammonium chloride) (pDADMAC) additive. ( a ) *Identification.* A wound dressing with pDADMAC additive is intended for use as a primary dressing for exuding wounds, 1st and 2d degree burns, and surgical wounds, to secure and prevent movement of a primary dressing, and as a wound packing.
( b ) *Classification.* Class II (special controls). The special control is: the FDA guidance document entitled “Class II Special Controls Guidance Document: Wound Dressing With Poly (Diallyl Dimethyl Ammonium Chloride) (pDADMAC) Additive.” See § 878.1(e) for availability of this guidance document.
[74 FR 53167, Oct. 16, 2009]
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.5810 External functional neuromuscular stimulator. ( a ) *Identification.* An external functional neuromuscular stimulator is an electrical stimulator that uses external electrodes for stimulating muscles in the leg and ankle of partially paralyzed patients (e.g., after stroke) to provide flexion of the foot and thus improve the patient's gait.
( b ) *Classification.* Class II (performance standards).
EXHIBIT 32.b



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of American Affordable Housing II Limited Partnership (the "Partnership") on Form 10-Q for the period ended September 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Marc N. Teal, Principal Financial Officer of the general partner of the general partner of the Partnership's general partner, C&M Management Inc., certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge, after due inquiry:



|(1) | The Report fully complies with the requirements of section 13(a)-15 or 15(d)-15 of the Securities and Exchange Act of 1934; and                         
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                         
|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership.



|                  |     |                            
|----------------- | --- | ---------------------------
|Date:             |     |                            
|November 14, 2008 | By: | /s/ Marc N. Teal           
|                  |     |                            
|                  |     | Marc N. Teal               
|                  |     | Principal Financial Officer

A signed original of this written statement required by Section 906, or other

document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Fund and will be retained by the Fund and furnished to the Securities and Exchange Commission or its staff upon request.
Support Documents for 

Significant New Use Rule (SNUR) on 

Premanufacture Notice (PMN) 

P-04-516 

EPA Docket EPA-HQ-OPPT-2011-0577 

EPA SANITIZED Page 1 of 26
Index

A-001 Structure Activity Team (SAT) Report for 

PMN P-04-516 

A-002 Initial Review Engineering Report for 

PMN P-04-516 

A-003 Initial Review Exposure Report for 

PMN P-04-516 

EPA SANITIZED Page 2 of 26
A-001 

Structure Activity Team (SAT) Report

for PMN P-04-516 

EPA SANITIZED Page 3 of 26
 

EPA SANITIZED Page 4 of 26
 

 

 

EPA SANITIZED Page 5 of 26
 

EPA SANITIZED Page 6 of 26
 

EPA SANITIZED Page 7 of 26
EPA SANITIZED Page 8 of 26
EPA SANITIZED Page 9 of 26
EPA SANITIZED Page 10 of 26
 

 

EPA SANITIZED Page 11 of 26
 

 

 

 

EPA SANITIZED Page 12 of 26
EPA SANITIZED Page 13 of 26
A-002 

Initial Review Engineering Report

for PMN P-04-516 

EPA SANITIZED Page 14 of 26
 

EPA SANITIZED Page 15 of 26
 

EPA SANITIZED Page 16 of 26
EPA SANITIZED Page 17 of 26
EPA SANITIZED Page 18 of 26
 

 

 

EPA SANITIZED Page 19 of 26
EPA SANITIZED Page 20 of 26
A-003 

Initial Review Exposure Report

for PMN P-04-516 

EPA SANITIZED Page 21 of 26
9/16/2004 Page of 

POST-FOCUS REVIEW EXPOSURE REPORT 

This report revised according to 9/16/2004 engineering report, P040516.en2. 

Case Number: P040516 Assessor: Flessner 

ENVIRONMENTAL RELEASES 

Scenario#: 1 Number of Release Sites: 

Release Activity: Manufacture 

Release Description: WATER LANDFILL INCINER LAND/INCIN FUGITIVE 

Total Releases: 

(kg/yr) (kg/yr) (kg/yr) (kg/yr) (kg/yr) 

Release Days/yr: 

Per Site Release: 

(kg/day) (kg/yr) (kg/yr) (kg/yr) (kg/day) 

Remarks: 

Consumer use expected? No, consumer use is not expected. 

EPA SANITIZED Page 22 of 26
POST-FOCUS REVIEW EXPOSURE REPORT Page of 

CASE NUMBER:P040516 

EPA SANITIZED Page 23 of 26
Page of 

POST-FOCUS REVIEW EXPOSURE REPORT 

Case Number: P040516 Assessor: 

ENVIRONMENTAL RELEASES 

Scenario#: 2 Number of Release Sites: 

Release Activity: Processing 

Release Description: WATER LANDFILL INCINER LAND/INCIN FUGITIVE 

Total Releases: 

(kg/yr) (kg/yr) (kg/yr) (kg/yr) (kg/yr) 

Release Days/yr: 

Per Site Release: 

(kg/day) (kg/yr) (kg/yr) (kg/yr) (kg/day) 

Remarks: 

 

EPA SANITIZED Page 24 of 26
POST-FOCUS REVIEW EXPOSURE REPORT Page of 

CASE NUMBER:P040516 

EPA SANITIZED Page 25 of 26
POST-FOCUS REVIEW EXPOSURE REPORT Page of 

CASE NUMBER:P040516 

EPA SANITIZED Page 26 of 26
#### Urban Redevelopment Commission of the City of Stamford *v.*Scalzi Motors and Service, Inc.

Submitted June 10

decided June 25, 1968

*Michael A. Catalano,*in support of the motion.

The motion by the defendant for review of the order by the trial court terminating the stay of execution in the appeal from the Superior Court in Fairfield County is denied.
[Federal Register Volume 75, Number 47 (Thursday, March 11, 2010)]
[Notices]
[Page 11534]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-5241]


=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-9126-1]


Notice of Charter Renewal for the Environmental Financial 
Advisory Board (EFAB)

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

    The Charter for the Environmental Protection Agency's Environmental 
Financial Advisory Board (EFAB) will be renewed for an additional two-
year period, as a necessary committee which is in the public interest, 
in accordance with the provisions of the Federal Advisory Committee Act 
(FACA), 5 U.S.C. App.2. The purpose of EFAB is to provide advice and 
recommendations to the Administrator of EPA on issues associated with 
environmental financing.
    It is determined that EFAB is in the public interest in connection 
with the performance of duties imposed on the Agency by law.
    Inquiries may be directed to Vanessa Bowie, Staff Director, Center 
for Environmental Finance, Ronald Reagan Building, 1200 Pennsylvania 
Ave., NW., Washington, DC 20460 (Mailcode 2731R), Telephone (202) 564-
5186, or <a href="/cdn-cgi/l/email-protection#b8dad7cfd1dd96ced9d6ddcbcbd9f8ddc8d996dfd7ce"><span class="__cf_email__" data-cfemail="e98b869e808cc79f88878c9a9a88a98c9988c78e869f">[email protected]</span></a>.

    Dated: February 24, 2010.
Joshua Baylson,
Associate Chief Financial Officer.
[FR Doc. 2010-5241 Filed 3-10-10; 8:45 am]
BILLING CODE P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
| (logo) WELLS FARGO | **Corporate Trust Services**

  MAC R1204-010  9062 Old Annapolis Road  Columbia, MD 21045  Tel: 410 884 2000  Fax: 410 715 2380 |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------|

 

 

Re: Annual Statement of Compliancefor Wells Fargo Commercial Mortgage Securities, Inc., Commercial MortgagePass-Through Certificates, Series 2015-LC22 

 

Per the Pooling andAdministration Agreement dated as of September 1, 2015 (the"Agreement"), the undersigned, a duly authorized officer of WellsFargo Bank, N.A., as Certificate Administrator ("Wells Fargo"),hereby certifies as follows as of and for the year ending December 31, 2016(the "Reporting Period"): 

 

(a) A review of Wells Fargo'sactivities during the Reporting Period and of its performance under theAgreement has been made under such officer's supervision; and 

 

(b) To the best of suchofficer's knowledge, based on such review, Wells Fargo has fulfilled all of itsobligations under the Agreement in all material respects throughout theReporting Period. 

 

 

February 27, 2017 

 

 

/s/ Brian Smith

BRIAN SMITH

Vice President

 

 

| Wells Fargo Bank, N.A. | (logo) Together we’ll  go far |
|------------------------|-------------------------------------|
| (logo) WELLS

           FARGO | **Commercial  Mortgage Servicing**D1050-084,  8th Floor  401 South Tryon St.  Charlotte, NC 28202  1-800-326-1334 |
|----------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------|

 

 

 **ANNUAL STATEMENT OFCOMPLIANCE**

 

 

Reference is hereby made to that certain Pooling and Servicing Agreementdated as of August 1, 2015, by and among WELLS FARGO COMMERCIAL MORTGAGESECURITIES, INC., as Depositor, WELLS FARGO BANK, NATIONAL ASSOCIATION, asGeneral Master Servicer, CWCAPITAL ASSET MANAGEMENT LLC, as General SpecialServicer, NATIONAL COOPERATIVE BANK, N.A., as NCB Master Servicer, NATIONALCOOPERATIVE BANK, N.A, as NCB Special Servicer, PENTALPHA SURVEILLANCE LLC, asTrust Advisor, WELLS FARGO BANK, NATIONAL ASSOCIATION, as CertificateAdministrator, as Tax Administrator and as Custodian and WILMINGTON TRUST,NATIONAL ASSOCIATION, as Trustee, with respect to Commercial MortgagePass-Through Certificates Series 2015-C30 (the "Agreement").Capitalized terms used herein not otherwise defined shall have the meaningsassigned in the Agreement.

 

Pursuant to Section 11.12 of this Agreement, I, Leslie Hayton,Managing Director of Commercial Mortgage Services do hereby certify that:

 

1.      A review of the activities of the General Master Servicer duringthe period from January 1, 2018 through December 31, 2018 (the “ReportingPeriod”), and of its performance per the Agreement during such period has beenmade under my supervision, and

 

2.      To the best of my knowledge, based on such review, the GeneralMaster Servicer, has fulfilled all of its obligations under this Agreement inall material respects throughout the Reporting Period.

 

 

IN WITNESS WHEREOF,the undersigned has executed this Certificate as of the 28th day of February 2019.

 

 

/s/Leslie Hayton

LeslieHayton

ManagingDirector

WellsFargo Bank

 

 

| Wells Fargo Bank,  N.A. | (logo) Together  we’ll go far |
|-------------------------|-------------------------------------|
<Page>

                                                                          [LOGO]

                       CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the use in this Post-Effective Amendment No. 12 to the
registration statement on Form N-4 (No. 033-73986) (the "Registration
Statement") of our report dated February 13, 2003, relating to the financial
statements of Fortis Benefits Insurance Company, which appears in such
Registration Statement. We also consent to the reference to us under the heading
"Independent Accountants" in such Registration Statement.

PRICEWATERHOUSECOOPERS LLP
Minneapolis, Minnesota
April 7, 2003
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

GURPREET SINGH,

Petitioner,

v.

JEFFERSON B. SESSIONS III, Attorney

General,

Respondent. No. 16

- 72041

Agency No. A201

- 295

- 482

MEMORANDUM *

On Petition for Review of an Order of the

Board of Immigration Appeals

Submitted February 13, 2018 **

Before: LEAVY, FERNANDEZ, and MURG U IA, Circuit Judges.

Gupreet Singh, a native and ci tizen of India, petitions for review of the

decision of the Board of Imm igration Appeals (“BIA”) affirming an immigration

judge’ s (“IJ”) decision deny ing his application for asylum and withholding of

removal. We have jurisdiction under 8 U.S.C. § 1252. We review for substantial

* This disposition is not appropriate for publication and is not precedent

except as provided by Ninth Circuit Rule 36

- 3.

** The panel unanimously concludes this case is suitable for decision

without oral argument. See Fed. R. App. P. 34(a)(2 ). 

# FILED

FEB 22 2018

MOLLY C. DWYER, CLER K

U.S. COURT OF APPEAL S2 16

- 72041

evidence the agency's factual findings, Zehatye v. Gonzales , 453 F.3d 1182, 1184

-

85 (9th Cir. 2006) , and we deny the petition for review.

Substantial evidence supports the agency’s finding that

, although Singh

established past persecution, the government rebutted Singh’s presumed well

founded fear of f

uture persecution with evidence that he could safely and

reasonably relocate within India to avoid harm. See 8 C.F.R. § 1208.13(b)(3);

Gonzalez

- Hernandez v. Ashcroft

, 336 F.3d 995, 999 (9th Cir. 2003)

. We reject

Singh’s contentions that the ag ency’ s relo cation analysis was insufficient and that

the BIA failed to adequately address his a rgument that the IJ’s analysis was

insufficient

. Thus, his asylum claim fails.

In this case, because Singh failed to establish eligibility for asylum, he failed

to satisfy the standard for withholding of removal. See Zehatye , 453 F.3d at 1190

.

PETITION FOR REVIEW DENIED.
# C_2015228EN.01002602.xml

| 13.7.2015 | EN | Official Journal of the European Union | C 228/26 |
| --- | --- | --- | --- |

13.7.2015

EN

Official Journal of the European Union

C 228/26

---

Order of the General Court of 8 May 2015 — Hoteles Catalonia v OHIM — Fundació Catalunya-La Pedrera, fundació especial (HOTEL CATALONIA LA PEDRERA)

(Case T-358/14) (1)

1

(2015/C 228/36)

Language of the case: Spanish

The President of the Seventh Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 253, 4.8.2014.

1

---
427 A.2d 1231

#### Commonwealth ex rel. Mary F. v. Ann P. H. Appeal of Mary F.

Submitted September 13, 1979.

Willis W. Berry, Jr., for appellant;

Sylvan D. Einhorn, for appellee.

Before SPAETH, HESTER and CAVANAUGH, JJ.

The order of the lower court is hereby affirmed.
Editorial Note on Part 892
Editorial Note: Nomenclature changes to part 892 appear at 73 FR 35341, June 23, 2008.

§ 892.5650 Manual radionuclide applicator system. ( a ) *Identification.* A manual radionuclide applicator system is a manually operated device intended to apply a radionuclide source into the body or to the surface of the body for radiation therapy. This generic type of device may include patient and equipment supports, component parts, treatment planning computer programs, and accessories.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 892.9.
[53 FR 1567, Jan. 20, 1988, as amended at 65 FR 2323, Jan. 14, 2000]
| (logo) WELLS  FARGO | **Commercial  Mortgage Servicing**D1050-084,  8th Floor  401 South Tryon St.  Charlotte, NC 28202  1-800-326-1334

 

  |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------|

**ANNUAL STATEMENT OFCOMPLIANCE**

 

 

Reference is hereby made to that certain Poolingand Servicing Agreement dated as of July 1, 2015, by and among J.P. MorganChase Commercial Mortgage Securities Corp., as Depositor, Wells Fargo Bank,National Association, as Master Servicer, Torchlight Loan Services, LLC, asSpecial Servicer, Wells Fargo Bank, National Association, as CertificateAdministrator, Wilmington Trust, National Association, as Trustee, andPentalpha Surveillance LLC, as Senior Trust Advisor with respect to CommercialMortgage Pass-Through Certificates Series 2015-C30 (the "Agreement").Capitalized terms used herein not otherwise defined shall have the meaningsassigned in the Agreement.

 

Pursuant to Section 11.09 of thisAgreement, I, Leslie Hayton, Managing Director of Commercial Mortgage Servicesdo hereby certify that:

 

1.       Areview of the activities of the Master Servicer during the period from January1, 2018 through December 31, 2018 (the “Reporting Period”), and of itsperformance per the Agreement during such period has been made under mysupervision, and

 

2.       To thebest of my knowledge, based on such review, the Master Servicer has fulfilledall of its obligations under the Agreement in all material respects throughoutthe Reporting Period.

 

 

IN WITNESS WHEREOF, the undersigned hasexecuted this Certificate as of the 28th day of February 2019.

 

 

/s/Leslie Hayton

LeslieHayton

ManagingDirector

WellsFargo Bank

 

 

| Wells  Fargo Bank, N.A. | (logo) Together  we’ll go far |
|-------------------------|-------------------------------------|
Editorial Note on Part 880
Editorial Note: Nomenclature changes to part 880 appear at 73 FR 35341, June 23, 2008.

§ 880.6070 Bed board. ( a ) *Identification.* A bed board is a device intended for medical purposes that consists of a stiff board used to increase the firmness of a bed.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 880.9. The device is also exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.
[45 FR 69682, Oct. 21, 1980, as amended at 66 FR 38805, July 25, 2001]
Editorial Note on Part 890
Editorial Note: Nomenclature changes to part 890 appear at 73 FR 35341, June 23, 2008.

§ 890.3640 Arm sling. ( a ) *Identification.* An arm sling is a device intended for medical purposes to immobilize the arm, by means of a fabric band suspended from around the neck.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 890.9. The device is also exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, regarding general requirements concerning records and § 820.198, regarding complaint files.
[48 FR 53047, Nov. 23, 1983, as amended at 66 FR 38817, July 25, 2001]
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.6160 Manual blood cell counting device. ( a ) *Identification.* A manual blood cell counting device is a device used to count red blood cells, white blood cells, or blood platelets.
( b ) *Classification.* Class I (general controls). This device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.
[45 FR 60605, Sept. 12, 1980, as amended at 54 FR 25045, June 12, 1989; 66 FR 38790, July 25, 2001]